Speaker: Joellen M. Schildkraut, PhD, Jules and Uldeen Terry Distinguished Professor of Women’s Health, Department of Epidemiology and the Center for Computational and Quantitative Genetics, Rollins School of Public Health, Emory University.
Researchers have learned more about an enzyme found to be overly expressed in patients with hereditary breast cancer, ovarian cancer and prostate cancer.
Speaker: Tyvette Hilliard, PhD, research assistant professor, University of Notre Dame. This presentation will be held in person and virtually over Zoom. Please register in advance if attending virtually.
Researchers led by Hector L. Franco, PhD, have determined for the first time, cell-by-cell, the genetic and epigenetic state of ovarian and endometrial tumors.
She ROCKS supports the work of UNC Lineberger’s Victoria Bae-Jump, MD, and her work focusing on advancing the prevention, early detection and treatment of ovarian cancer.
Dale Ramsden, PhD, Gaorav Gupta, MD, PhD, and team will study an enzyme that is part of an important pathway that repairs damage to genomes.
The research of Paul Goodfellow, PhD, a professor in the Department of Obstetrics and Gynecology at Ohio State and a member of the OSUCCC – James Molecular Carcinogenesis and Chemoprevention Program, centers on understanding the role that loss of DNA-mismatch repair plays in uterine tumor initiation and progression, and on learning how key molecular events … Read more
